Literature DB >> 12565083

Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction.

Harry P Selker1, Merritt H Raitt, Christopher H Schmid, Michael M Laks, Joni R Beshansky, John L Griffith, Robert M Califf, Ronald H Selvester, Charles Maynard, Ralph B D'Agostino, W Douglas Weaver.   

Abstract

To understand predictors of cardiac arrest early in acute myocardial infarction (AMI), for the Thrombolytic Predictive Instrument, we developed a multivariable regression model predicting primary cardiac arrest using time-dependent variables based on a case-control study of emergency department (ED) patients with AMI: 65 cases with sudden cardiac arrest and 258 without cardiac arrest. Within the first hour of AMI symptom onset, adjusting for age, systolic blood pressure, serum potassium, and infarct size, increased risk of cardiac arrest was associated with electrocardiographic prolonged QTc interval and a greater sum of ST-segment elevation. After 1 hour, the effect of ST-segment elevation was much reduced and the effect of the QTc interval was reversed, so prolonged QTc appeared protective. Accordingly, for patients presenting 30 minutes after chest pain onset, compared with a QTc of 0.44, the risk for cardiac arrest for patients with QTc of 0.50 was more than doubled (odds ratio [OR] 2.20, 95% confidence intervals [CI] 1.17 to 4.13), whereas for those presenting after an hour, it was much lower (e.g., at 1.5 hours, OR 0.21, 95% CI 0.06 to 0.73). Patients presenting 30 minutes after chest pain onset with a sum of ST elevation of 20 mm had a threefold higher risk than patients with a sum of ST elevation of 5 mm (OR 3.37, 95% CI 1.83 to 6.20). However, if presenting 1.5 hours after chest pain onset, the risk was barely elevated (OR 1.18; 95% CI 1.09 to 1.29). Thrombolytic therapy was protective, halving the odds of cardiac arrest (OR 0.51, 95% CI 0.27 to 0.93). Thus, the relation of prolonged QTc interval and substantial ST segment elevation to cardiac arrest in AMI may be obscured because patients with these risks are more likely to die soon after AMI onset, before ED presentation, and are thereby unavailable for study. Those with prolonged QTc or substantial ST elevation who survive the initial 1.5-hour period are those less susceptible to these risks.

Entities:  

Mesh:

Year:  2003        PMID: 12565083     DOI: 10.1016/s0002-9149(02)03155-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Authors:  Harry P Selker; Joni R Beshansky; Patricia R Sheehan; Joseph M Massaro; John L Griffith; Ralph B D'Agostino; Robin Ruthazer; James M Atkins; Assaad J Sayah; Michael K Levy; Michael E Richards; Tom P Aufderheide; Darren A Braude; Ronald G Pirrallo; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Lionel H Opie; Charles E Rackley; Carl S Apstein; James E Udelson
Journal:  JAMA       Date:  2012-03-27       Impact factor: 56.272

2.  Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial.

Authors:  K L Ellis; Y Zhou; J R Beshansky; E Ainehsazan; Y Yang; H P Selker; G S Huggins; L A Cupples; I Peter
Journal:  Pharmacogenomics J       Date:  2014-08-19       Impact factor: 3.550

3.  Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.

Authors:  K L Ellis; Y Zhou; J R Beshansky; E Ainehsazan; H P Selker; L A Cupples; G S Huggins; I Peter
Journal:  Pharmacogenomics J       Date:  2015-03-17       Impact factor: 3.550

4.  Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study.

Authors:  Alison L Sullivan; Joni R Beshansky; Robin Ruthazer; David H Murman; Timothy J Mader; Harry P Selker
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-01-14

5.  A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study,,.

Authors:  Madhab Ray; Robin Ruthazer; Joni R Beshansky; David M Kent; Jayanta T Mukherjee; Hadeel Alkofide; Harry P Selker
Journal:  Int J Cardiol Heart Vasc       Date:  2015-08-27

6.  Plasma homocysteine levels associated with a corrected QT interval.

Authors:  Zhao Li; Xiaofan Guo; Guozhe Sun; Liqiang Zheng; Yingxian Sun; Yamin Liu; Maria Roselle Abraham
Journal:  BMC Cardiovasc Disord       Date:  2017-07-11       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.